In contrast to the substantial evidence for attenuation of the glomerular lesions by a low-protein (LP) diet, it remains to be determined whether and how such a diet lessens the progression of tubulointerstitial lesions, which show the strongest correlation with renal function. Chronic unilateral ureteral obstruction (UUO) results in interstitial fibrosis of the affected kidney. We investigated the therapeutic effects of an LP diet on the progression of interstitial fibrosis in UUO mice. Sixty ICR mice underwent UUO or sham operation; half of these mice were fed a normal-protein (NP) and the other half a LP diet. They were sacrificed at 3, 7 and 14 days postoperatively. The degree of tubular lesion, the distribution of transforming growth factor-β (TGF-β), α-smooth muscle actin and fibronectin and the activated TGF-β1 level were determined. The LP diet significantly reduced the progression of tubular injury, depositions of fibronectin, tubulointerstitial myofibroblast formation, the interstitial expression of TGF-β-positive cells (at 14 days; NP = 6.91 ± 3.35 vs. LP = 1.67 ± 0.41; p < 0.005), and renal active TGF-β1 concentration (at 14 days; NP = 5.72 ± 2.03 vs. LP = 2.96 ± 0.72; p < 0.01). We conclude that protein restriction may aid the attenuation of progression of tubulointerstitial fibrosis through the reduction in tubulointerstitial expression of TGF-β.

Keywords:
Mice, Protein restriction, Transforming growth factor-beta, Tubulointerstitial fibrosis, Unilateral ureteral obstruction
1.
Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982;307:652–659.
2.
Schena FP, Gesualdo L, Grandaliano G, Montinaro V: Progression of renal damage in human glomerulonephritides: Is there sleight of hand in winning the game? Kidney Int 1997;52:1439–1457.
3.
Okuda S, Nakamura T, Yamamoto T, Ruoslahtie E, Border W: Dietary protein restriction rapidly reduces transforming growth factor B expression in experimental glomerulonephritis. Proc Natl Acad Sci USA 1991;88:9765–9769.
4.
Fukui M, Nakamura T, Ebihara I, Nagaoka I, Tomino Y, Koide H: Low protein diet attenuates increased gene expression of platelet-derived growth factor and transforming growth factor-β in experimental glomerular sclerosis. J Lab Clin Med 1993;121:224–234.
5.
Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993;92:2597–2601
6.
Border W, Noble N: Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;10:1286–1292.
7.
Kliem V, Johnson RJ, Alpers CE, Yoshimura A, Couser WG, Koch KM, Floege J: Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 1996;49:666–678.
8.
Eddy A: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996;7:2495–2508.
9.
Bohle A, Strutz F, Muller GA: On the pathogenesis of chronic renal failure in primary glomerulopathies: A view from the interstitium (editorial). Exp Nephrol 1994;2:205–210.
10.
Risdon R, Sloper J, Wardener H: Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 1968;ii: 363–366.
11.
Klahr S, Harris K, Purkerson M: Effects of obstruction on renal functions. Pediatr Nephrol 1988;2:34–42.
12.
Klahr S: New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy. Am J Kidney Dis 1991;18:689–699.
13.
Diamond J, Ricardo S, Klahr S: Mechanisms of interstitial fibrosis in obstructive nephropathy. Semin Nephrol 1998;18:594–602.
14.
Diamond J, Kees-Folts D, Ding G, Frye J, Restrepo N: Macrophages, monocyte chemoattractant peptide-1, and TGF-beta 1 in experimental hydronephrosis. Am J Physiol 1994;266:F926–933.
15.
Pimentel JJ, Sundell C, Wang S, Kopp J, Montero A, Martinez-Maldonado M: Role of angiotensin II in the expression and regulation of transforming growth factor-beta in obstructive nephropathy. Kidney Int 1995;48:1233–1246.
16.
Diamond JR, van GH, Ding G, Engelmyer E: Myofibroblasts in experimental hydronephrosis. Am J Pathol 1995;146:121–129.
17.
Kaneto H, Morrissey J, McCracken R, Reyes A, Klahr S: Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int 1994;45:1637–1647.
18.
Mizuno S, Kurosawa T, Matsumoto K, Horikawa Y, Okamoto M, Nakamura T: Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest 1998;101:1827–1834.
19.
Zhang G, Moorhead PJ, el NA: Myofibroblasts and the progression of experimental glomerulonephritis. Exp Nephrol 1995;3:308–318.
20.
Neugarten J, Schacht R, Baldwin D: Amelioration of experimental glomerulonephritis by dietary protein restriction. Kidney Int 1983;24:595–601.
21.
Nagle R, Bulger R: Unilateral obstructive nephropathy in the rabbit. II. Late morphologic changes. Lab Invest 1978;38:270–278.
22.
Sharma A, Mauer S, Kim Y, Michael A: Interstitial fibrosis in obstructive nephropathy. Kidney Int 1993;774–788.
23.
Ishidoya S, Morrissey J, McCracken R, Klahr S: Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int 1996;49:1110–1119.
24.
Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl P, Gordon K, Seifert RA, Bowen PD, Couser WG, Johnson RJ: Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 1992;41:297–309.
25.
Mizuno S, Yue BF, Okamoto M, Horikawa Y, Kurosawa T: Diffuse glomerulosclerosis without tubular injury does not directly manifest renal dysfunction in nephrotic mice (ICGN strain). Exp Nephrol 1997;5:498–507.
26.
Mizuno S, Horikawa Y, B-F Y, Okamoto M, Kurosawa T: Nephrotic mice (ICGN strain): A model of diffuse mesangial sclerosis in infantile nephrotic syndrome. Am J Nephrol 1998;19:73–82.
27.
Mizuno S, Horikawa Y, Okamoto M, Kurosawa T: Preventive effect of ACE inhibitor on interstitial myofibroblast formation and matrix deposition in a nephrotic model. Renal Failure 1998;20:481–491.
28.
Mizuno S, Horikawa Y, Okamoto M, Kurosawa T: Ace inhibitor suppresses tubular expression of PDGF and attenuates progression of tubulo-interstitial fibrosis in a nephrotic mouse model. Nephron 1998;79:503–504.
29.
Nahas A, Muchaneta-Kubara E, Essawy M, Soylemezoglu O: Renal fibrosis: Insights into pathogenesis and treatment. Int J Biochem Cell Biol 1997;29:55–62.
30.
Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM: Renal injury from angiotensin II-mediated hypertension. Hypertension 1992;19:464–474.
31.
Tang WW, Ulich TR, Lacey DL, Hill DC, Qi M, Kaufman SA, Van GY, Tarpley JE, Yee JS: Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 1996;148:1169–1180.
32.
Zhang K, MD Rekhter, D Gordon, SH Phan: Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. Am J Pathol 1994;145:114–125.
33.
Gressner AM: Cytokines and cellular crosstalk involved in the activation of fat-storing cells. J Hepatol 1995;22:28–36.
34.
Goumenos DS, Brown CB, Shortland J, Am N: Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Nephrol Dial Transplant 1994;9:1418–1425.
35.
Boukhalfa G, Desmouliere A, Rondeau E, Gabbiani G, Sraer JD: Relationship between alpha-smooth muscle actin expression and fibrotic changes in human kidney. Exp Nephrol 1996;4:241–247.
36.
Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G: Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993;122:103–111.
37.
Kagami S, W Border, D Miller, N Noble: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 1994;93:2431–2437.
38.
Rosenberg M, D Chmielewski, T Hostetter: Effect of dietary protein on rat renin and angiotensinogen gene expression. J Clin Invest 1990;85:1144–1149.
39.
Ichikawa I, Purkerson ML, Yaes J, Klahr S: Dietary protein intake conditions the degree of renal vasoconstriction in acute renal failure caused by ureteral obstruction. Am J Physiol 1985;249:F54–F61.
40.
Sahai A, Mei C, Schrier RW, Tannen RL: Mechanisms of chronic hypoxia-induced renal cell growth. Kidney Int 1999;56:1277–1281.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.